Funder: Breakthrough T1D
Due Dates: October 29, 2025 (Letter of Intent) | January 13, 2026 (Full proposal)
Funding Amounts: Up to $3,000,000 total for up to 3 years; budget must match project scope; smaller budgets considered.
Summary: Supports clinical trials advancing therapies to improve cardiovascular outcomes in people with type 1 diabetes.
Key Information: LOI approval required to submit a full proposal; industry-academic collaborations encouraged.